Interactions between FGFR2 and RSK2—implications for breast cancer prognosis-Reference-Cited by-同舟云学术

Interactions between FGFR2 and RSK2—implications for breast cancer prognosis

Published:2016-07-30 Issue:10 Volume:37 Page:13721-13731
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol.

Author:

Czaplinska Dominika,Mieczkowski Kamil,Supernat Anna,Skladanowski Andrzej C.,Kordek Radzislaw,Biernat Wojciech,Zaczek Anna J.,Romanska Hanna M.,Sadej Rafal^ORCID

Funder

National Science Center

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13277-016-5266-9.pdf

Reference26 articles.

1. Wesche J, Haglund K, Haugsten EM. Fibroblast growth factors and their receptors in cancer. Biochem J. 2011;437:199–213.

2. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, Wacholder S, Wang Z, Welch R, Hutchinson A, Wang J, Yu K, Chatterjee N, Orr N, Willett WC, Colditz GA, Ziegler RG, Berg CD, Buys SS, McCarty CA, Feigelson HS, Calle EE, Thun MJ, Hayes RB, Tucker M, Gerhard DS, Fraumeni JF, Hoover RN, Thomas G, SJ C. A genome-wide association study identifies alleles in fgfr2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet. 2007;39:870–4.

3. Sun S, Jiang Y, Zhang G, Song H, Zhang X, Zhang Y, Liang X, Sun Q, Pang D. Increased expression of fibroblastic growth factor receptor 2 is correlated with poor prognosis in patients with breast cancer. J Surg Oncol. 2012;105:773–9.

4. Heiskanen M, Kononen J, Bärlund M, Torhorst J, Sauter G, Kallioniemi A, Kallioniemi O. Cgh, cdna and tissue microarray analyses implicate fgfr2 amplification in a small subset of breast tumors. Anal Cell Pathol. 2001;22:229–34.

5. Turner N, Lambros MB, Horlings HM, Pearson A, Sharpe R, Natrajan R, Geyer FC, van Kouwenhove M, Kreike B, Mackay A, Ashworth A, van de Vijver MJ, Reis-Filho JS. Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets. Oncogene. 2010;29:2013–23.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing Pathology with Artificial Intelligence: Innovations in Immunohistochemistry;Journal of Personalized Medicine;2024-06-27

2. FGFR2-triggered autophagy and activation of Nrf-2 reduce breast cancer cell response to anti-ER drugs;Cellular & Molecular Biology Letters;2024-05-14

3. FGFR families: biological functions and therapeutic interventions in tumors;MedComm;2023-09-23

4. Syndecan-4 proteoliposomes enhance revascularization in a rabbit hind limb ischemia model of peripheral ischemia;Acta Biomaterialia;2023-09

5. Circ_0008234 regulates the biological process of gallbladder carcinoma by targeting the miR-204-5p/FGFR2 axis;HISTOL HISTOPATHOL;2023